Niobium
- Generic Name
- Niobium
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- Nb
- CAS Number
- 7440-03-1
- Unique Ingredient Identifier
- 05175J654G
- Background
Niobium has been used in trials studying the treatment of Obesity and Overweight.
- Associated Conditions
- -
- Associated Therapies
- -
Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Orexigen Therapeutics, Inc
- Target Recruit Count
- 242
- Registration Number
- NCT01764386
- Locations
- 🇺🇸
Radiant Research-Akron, Akron, Ohio, United States
🇺🇸PMG Research of Winston-Salem, Hickory, North Carolina, United States
🇺🇸PMG Research of Salisbury, Salisbury, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath